Benitec Biopharma Inc. (BNTC) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Benitec Biopharma Inc. (BNTC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $305.8M, listed on NASDAQ, employing roughly 16 people, carrying a beta of 0.28 to the broader market. Benitec Biopharma Inc. Led by Jerel A. Banks, public since 2014-06-24.
Snapshot as of May 15, 2026.
- Spot Price
- $11.34
- ATM IV
- 191.3%
- IV Skew 25Δ
- 0.245
- IV Rank
- 45.7%
- IV Percentile
- 51.6%
- Term Structure Slope
- -0.524
As of May 15, 2026, Benitec Biopharma Inc. (BNTC) at-the-money implied volatility is 191.3%. IV rank is 45.7% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 51.6%. The 25-delta skew is +0.245: calls carry premium over puts, indicating upside speculation or squeeze risk. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
BNTC Strategy Selection at Current Volatility Levels
For Benitec Biopharma Inc. options at 191.3% ATM IV, mid-range IV rank (45.7%) is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. The 25-delta skew tilts to calls, so call-credit spreads or covered-call writes harvest more premium than put-credit spreads of the same width. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked BNTC volatility skew questions
- What is the current BNTC ATM implied volatility?
- As of May 15, 2026, Benitec Biopharma Inc. (BNTC) at-the-money implied volatility is 191.3%. IV rank is 45.7% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is BNTC IV high or low historically?
- IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.
- What does BNTC volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Benitec Biopharma Inc. shows upside-skewed pricing: 25-delta calls trade richer than 25-delta puts, often reflecting upside speculation or squeeze risk. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.